IL68497A0 - Benzoazacycloalkyl-spiro-imidazolidines,their preparation and pharmaceutical compositions containing them - Google Patents

Benzoazacycloalkyl-spiro-imidazolidines,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL68497A0
IL68497A0 IL68497A IL6849783A IL68497A0 IL 68497 A0 IL68497 A0 IL 68497A0 IL 68497 A IL68497 A IL 68497A IL 6849783 A IL6849783 A IL 6849783A IL 68497 A0 IL68497 A0 IL 68497A0
Authority
IL
Israel
Prior art keywords
benzoazacycloalkyl
imidazolidines
spiro
preparation
pharmaceutical compositions
Prior art date
Application number
IL68497A
Other languages
English (en)
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of IL68497A0 publication Critical patent/IL68497A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IL68497A 1982-04-27 1983-04-26 Benzoazacycloalkyl-spiro-imidazolidines,their preparation and pharmaceutical compositions containing them IL68497A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8207203A FR2525603A1 (fr) 1982-04-27 1982-04-27 Benzoazacycloalkyl-spiro-imidazolinines, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
IL68497A0 true IL68497A0 (en) 1983-07-31

Family

ID=9273425

Family Applications (1)

Application Number Title Priority Date Filing Date
IL68497A IL68497A0 (en) 1982-04-27 1983-04-26 Benzoazacycloalkyl-spiro-imidazolidines,their preparation and pharmaceutical compositions containing them

Country Status (22)

Country Link
JP (1) JPS5910584A (OSRAM)
KR (1) KR840004428A (OSRAM)
AT (1) ATA125383A (OSRAM)
AU (1) AU1395383A (OSRAM)
BE (1) BE896572A (OSRAM)
DD (1) DD209833A5 (OSRAM)
DE (1) DE3315106A1 (OSRAM)
DK (1) DK183583A (OSRAM)
ES (1) ES521895A0 (OSRAM)
FR (1) FR2525603A1 (OSRAM)
GB (1) GB2133401B (OSRAM)
GR (1) GR78481B (OSRAM)
IL (1) IL68497A0 (OSRAM)
IT (1) IT1167123B (OSRAM)
LU (1) LU84770A1 (OSRAM)
MA (1) MA19783A1 (OSRAM)
NL (1) NL8301476A (OSRAM)
NO (1) NO831473L (OSRAM)
OA (1) OA07412A (OSRAM)
PT (1) PT76595B (OSRAM)
SE (1) SE8302347L (OSRAM)
ZA (1) ZA832927B (OSRAM)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU617541B2 (en) * 1988-10-20 1991-11-28 Wyeth Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
US4927831A (en) * 1988-10-20 1990-05-22 American Home Products Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
WO2005019179A2 (en) 2003-06-17 2005-03-03 Arena Pharmaceuticals, Inc. Benzazepine derivatives useful for the treatment of 5ht2c receptor associated diseases
NZ578503A (en) 2003-06-17 2011-02-25 Arena Pharm Inc Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases
WO2006069363A2 (en) 2004-12-21 2006-06-29 Arena Pharmaceuticals, Inc. Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
DK1833473T3 (da) 2004-12-23 2010-01-11 Arena Pharm Inc 5HT2C-Receptormodulator-sammensætninger og metoder for anvendelse
EP2001852A2 (en) 2006-04-03 2008-12-17 Arena Pharmaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto
EP2099743B1 (en) 2006-12-05 2014-08-27 Arena Pharmaceuticals, Inc. Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
JP5491421B2 (ja) 2008-03-04 2014-05-14 アリーナ ファーマシューティカルズ, インコーポレイテッド 5−ht2cアゴニストである(r)−8−クロロ−1−メチル−2,3,4,5−テトラヒドロ−1h−3−ベンゾアゼピンに関連する中間体の調製のためのプロセス
WO2010148207A2 (en) 2009-06-18 2010-12-23 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
WO2011153206A1 (en) 2010-06-02 2011-12-08 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
CN103189360A (zh) 2010-09-01 2013-07-03 艾尼纳制药公司 5-ht2c激动剂的非吸湿性盐
CA2808909A1 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Salts of lorcaserin with optically active acids
KR20140091458A (ko) 2010-09-01 2014-07-21 아레나 파마슈티칼스, 인크. 신장 손상을 갖는 개체에 대한 로카세린의 투여
CN107669687A (zh) 2010-09-01 2018-02-09 艾尼纳制药公司 用于体重控制的5‑ht2c激动剂的调节释放剂型
JP2015534563A (ja) 2012-10-09 2015-12-03 アリーナ ファーマシューティカルズ, インコーポレイテッド 体重管理の方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4209630A (en) * 1976-10-18 1980-06-24 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives

Also Published As

Publication number Publication date
GB2133401B (en) 1985-10-23
DE3315106A1 (de) 1983-11-03
NO831473L (no) 1983-10-28
NL8301476A (nl) 1983-11-16
IT1167123B (it) 1987-05-13
GB8311508D0 (en) 1983-06-02
KR840004428A (ko) 1984-10-15
MA19783A1 (fr) 1983-12-31
DD209833A5 (de) 1984-05-23
PT76595A (fr) 1983-05-01
SE8302347D0 (sv) 1983-04-26
OA07412A (fr) 1984-11-30
BE896572A (fr) 1983-10-26
IT8348155A0 (it) 1983-04-26
FR2525603B1 (OSRAM) 1984-09-14
GB2133401A (en) 1984-07-25
ATA125383A (de) 1986-05-15
SE8302347L (sv) 1983-10-28
LU84770A1 (fr) 1984-11-28
ZA832927B (en) 1984-06-27
ES8405796A1 (es) 1984-06-16
DK183583A (da) 1983-10-28
DK183583D0 (da) 1983-04-26
JPS5910584A (ja) 1984-01-20
ES521895A0 (es) 1984-06-16
FR2525603A1 (fr) 1983-10-28
GR78481B (OSRAM) 1984-09-27
AU1395383A (en) 1983-11-03
PT76595B (fr) 1986-01-21

Similar Documents

Publication Publication Date Title
IL67826A0 (en) Pyrazolooxazines,pyrazolothiazines and pyrazoloquinolines,their preparation and pharmaceutical compositions containing them
IL69955A0 (en) 1-phenyl-2-piperidinoalkanol derivatives,their preparation and pharmaceutical compositions containing them
IL68913A (en) 3-aminoalkyl-1h-indole-5-alkan-sulphonamide derivatives,their preparation and pharmaceutical compositions containing them
DE3468030D1 (en) 13-alpha-alkyl gonanes, their preparation and pharmaceutical compositions containing them
IL69157A0 (en) Fluoromorphinan derivatives,their preparation and pharmaceutical compositions containing them
IL66099A0 (en) N-aryl-piperazinealkanamides,their preparation and pharmaceutical compositions containing them
IL71475A0 (en) N-aryl-alpha-amino-carboxamides,their preparation and pharmaceutical compositions containing them
IL73951A0 (en) 2-phenyl-imidazoles,their preparation and pharmaceutical compositions containing them
IL66683A0 (en) Benzo-heterocycles,their preparation and pharmaceutical compositions containing them
IL68360A (en) Imidazopyrazolopyrimidine derivatives,their preparation and pharmaceutical compositions containing them
IL64444A0 (en) 8-arylalkyl-3-phenyl-3-nortropanols,their preparation and pharmaceutical compositions containing them
IL68817A0 (en) Oxoazetidine derivatives,their preparation and pharmaceutical compositions containing them
IL68497A0 (en) Benzoazacycloalkyl-spiro-imidazolidines,their preparation and pharmaceutical compositions containing them
IL68586A0 (en) 4-aryl-4-piperidinecarbinols,their preparation and pharmaceutical compositions containing them
IL68699A0 (en) 3-phenoxy-1-azetidinecarboxamides,their preparation and pharmaceutical compositions containing them
IL71419A0 (en) Phenylaminobenzenealkanols,their preparation and pharmaceutical compositions containing them
IL62495A0 (en) Pyrimidyl-quinazolines,their preparation and pharmaceutical compositions containing them
IL68496A (en) 8-heteroarylalkyl-ergoline derivatives,their preparation and pharmaceutical compositions containing them
IL72307A0 (en) Pyridinyl-2-pyrimidinamines,their preparation and pharmaceutical compositions containing them
DE3380093D1 (en) 3-aminopropoxyphenyl derivatives, their preparation and pharmaceutical compositions containing them
IL70158A (en) Tetrahydronaphthalene-carboxamides,their preparation and pharmaceutical compositions comprising them
IL70508A0 (en) Aralkyltriazole derivatives,their preparation and pharmaceutical compositions containing them
IL71110A0 (en) Azolylmethylcycloalkanes,their preparation and pharmaceutical compositions containing them
IL71661A0 (en) 4-phenyl-tetrahydro-furano-pyridines,their preparation and pharmaceutical compositions containing them
IL65177A0 (en) Fluoroprostacylins,their preparation and pharmaceutical compositions containing them